NASDAQ · TDAC
Translational Development Acquisition Corp.
$10.85$0.00 (0.0%)
Translational Development Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
Loading market information…
NASDAQ · ATMC · USD
Stock price, earnings
Quote as of Sep 4, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
AlphaTime Acquisition Corp’s quoted price sits in the upper half of its reported 52-week range, 1.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow AlphaTime Acquisition Corp’s reporting calendar.
THE COMPANY BEHIND THE TICKER
AlphaTime Acquisition Corp, established in New York, New York, in 2021, operates as a subsidiary of Alphamade Holding LP. The company's primary objective is to execute strategic business combinations—such as mergers, share exchanges, asset acquisitions, share purchases, or reorganizations—with other entities.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.85$0.00 (0.0%)
Translational Development Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
$12.20$0.00 (0.0%)
Oak Woods Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 6.15% below the high.
$13.45+$0.45 (+3.46%)
dMY Squared Technology Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 13.38% below the high.
$12.17+$0.02 (+0.16%)
Horizon Space Acquisition I Corp. Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 58.94% below the high.
$11.57$0.00 (0.0%)
ESH Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.15% below the high.
$11.00$0.00 (0.0%)
Four Leaf Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 14.0% below the high.
$0.40$0.00 (0.0%)
Quetta Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 83.33% below the high.
$12.55$0.00 (0.0%)
WinVest Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
